CA3185355C - Dinucleotides 3'3' cycliques comprenant un alcenylene
- Google Patents
Dinucleotides 3'3' cycliques comprenant un alcenylene
Info
Publication number
CA3185355C
CA3185355CCA3185355ACA3185355ACA3185355CCA 3185355 CCA3185355 CCA 3185355CCA 3185355 ACA3185355 ACA 3185355ACA 3185355 ACA3185355 ACA 3185355ACA 3185355 CCA3185355 CCA 3185355C
Authority
CA
Canada
Prior art keywords
independently
alkyl
compound
alkenyl
mhz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Institute of Organic Chemistry and Biochemistry of ASCR vvi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20185156.5Aexternal-prioritypatent/EP3936514B1/fr
Application filed by Institute of Organic Chemistry and Biochemistry of ASCR vvifiledCriticalInstitute of Organic Chemistry and Biochemistry of ASCR vvi
Publication of CA3185355A1publicationCriticalpatent/CA3185355A1/fr
Application grantedgrantedCritical
Publication of CA3185355CpublicationCriticalpatent/CA3185355C/fr
La présente divulgation concerne des dinucléotides phosphonates 3'3' cycliques de formule générale (J), leurs sels pharmaceutiquement acceptables, leur composition pharmaceutique et des combinaisons desdites substances et d'autres médicaments ou produits pharmaceutiques. L'invention concerne également l'utilisation desdits composés pour le traitement ou la prévention de maladies ou d'affections pouvant être modifiées par la modulation de la protéine STING, tels que le cancer ou des maladies virales, allergiques et inflammatoires. En outre, ces substances peuvent être utilisées comme adjuvants dans des vaccins. (Formule (J))
CA3185355A2020-07-102021-04-15Dinucleotides 3'3' cycliques comprenant un alcenylene
ActiveCA3185355C
(fr)